|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
5,560,000,000 |
Market
Cap: |
157.79(B) |
Last
Volume: |
23,526,547 |
Avg
Vol: |
30,558,062 |
52
Week Range: |
$25.26 - $40.28 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 6.5 |
Insider 3/6 Months : 7.1 |
|
Guru Rank Number : 710 |
Guru Rank Value : 1.7 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Pfizer is a research-based biopharmaceutical company. Co. is engaged in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products. Co.'s business includes: internal medicine, which includes cardiovascular metabolic and pain products; oncology, which includes products in biologics, small molecules, immunotherapies, and biosimilars for cancers; hospital, which includes Co.'s portfolio of sterile injectable and anti-infective medicines, as well as Pfizer CentreOne; vaccines, which includes vaccines brands in pneumococcal disease, meningococcal disease, tick-borne encephalitis and COVID-19; inflammation and immunology; and rare disease.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
3,000 |
3,000 |
5,000 |
Total Buy Value |
$0 |
$79,401 |
$79,401 |
$156,406 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
3 |
Total Shares Sold |
0 |
0 |
0 |
18,130 |
Total Sell Value |
$0 |
$0 |
$0 |
$826,281 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Read Ian C |
Chairman & CEO |
|
2017-02-27 |
4 |
D |
$34.28 |
$3,743,993 |
D/D |
(109,218) |
541,531 |
|
- |
|
Read Ian C |
Chairman & CEO |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
110,011 |
650,749 |
|
- |
|
Dolsten Mikael |
President R&D |
|
2017-02-27 |
4 |
S |
$34.25 |
$2,016,244 |
D/D |
(58,846) |
80,288 |
|
- |
|
Dolsten Mikael |
President R&D |
|
2017-02-27 |
4 |
D |
$34.28 |
$1,130,589 |
D/D |
(32,981) |
132,479 |
|
- |
|
Dolsten Mikael |
President R&D |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
31,800 |
172,115 |
|
- |
|
Damelio Frank A |
Executive Vice President |
|
2017-02-27 |
4 |
D |
$34.28 |
$1,298,664 |
D/D |
(37,884) |
431,798 |
|
- |
|
Damelio Frank A |
Executive Vice President |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
36,528 |
469,682 |
|
- |
|
Susman Sally |
Executive Vice President |
|
2017-02-27 |
4 |
D |
$34.28 |
$332,585 |
D/D |
(9,702) |
170,515 |
|
- |
|
Susman Sally |
Executive Vice President |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,189 |
180,217 |
|
- |
|
Lewis-Hall Freda C |
Executive Vice President |
|
2017-02-27 |
4 |
D |
$34.28 |
$580,566 |
D/D |
(16,936) |
221,623 |
|
- |
|
Lewis-Hall Freda C |
Executive Vice President |
|
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
16,329 |
238,559 |
|
- |
|
Lewis-Hall Freda C |
Executive Vice President |
|
2017-02-23 |
4 |
D |
$32.49 |
$2,412,263 |
D/D |
(73,126) |
222,230 |
|
- |
|
Lewis-Hall Freda C |
Executive Vice President |
|
2017-02-23 |
4 |
OE |
$21.03 |
$2,169,350 |
D/D |
103,155 |
295,356 |
|
- |
|
Read Ian C |
Chairman & CEO |
|
2017-02-23 |
4 |
D |
$32.49 |
$19,269,466 |
D/D |
(583,355) |
540,738 |
|
- |
|
Read Ian C |
Chairman & CEO |
|
2017-02-23 |
4 |
OE |
$21.03 |
$16,589,200 |
D/D |
788,835 |
1,124,093 |
|
- |
|
Young John D |
Group President |
|
2017-02-23 |
4 |
D |
$32.49 |
$1,161,513 |
D/D |
(35,253) |
137,289 |
|
- |
|
Young John D |
Group President |
|
2017-02-23 |
4 |
OE |
$21.03 |
$1,084,685 |
D/D |
51,578 |
172,542 |
|
- |
|
Susman Sally |
Executive Vice President |
|
2017-02-23 |
4 |
D |
$32.49 |
$2,798,508 |
D/D |
(84,737) |
163,028 |
|
- |
|
Susman Sally |
Executive Vice President |
|
2017-02-23 |
4 |
OE |
$21.03 |
$2,424,570 |
D/D |
115,291 |
247,765 |
|
- |
|
Olson Laurie J |
Executive Vice President |
|
2017-02-23 |
4 |
D |
$32.49 |
$608,776 |
D/D |
(18,483) |
80,741 |
|
- |
|
Olson Laurie J |
Executive Vice President |
|
2017-02-23 |
4 |
OE |
$21.03 |
$574,245 |
D/D |
27,306 |
99,224 |
|
- |
|
Mackenzie Alexander R |
Executive Vice President |
|
2017-02-23 |
4 |
D |
$34.06 |
$442,201 |
D/D |
(12,983) |
158,049 |
|
- |
|
Mackenzie Alexander R |
Executive Vice President |
|
2017-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
30,839 |
171,032 |
|
- |
|
Lund-Jurgensen Kirsten |
Executive Vice President |
|
2017-02-23 |
4 |
D |
$32.49 |
$464,750 |
D/D |
(14,119) |
19,729 |
|
- |
|
Lund-Jurgensen Kirsten |
Executive Vice President |
|
2017-02-23 |
4 |
OE |
$21.03 |
$446,635 |
D/D |
21,238 |
33,848 |
|
- |
|
1390 Records found
|
|
Page 20 of 56 |
|
|